Selenium in cancer prevention: Clinical issues and implications

Cancer Investigation

Volumn 19, Issue 5, 2001, Pages 540-553

  Raich, Peter C ^a   Lü, Junxuan ^a   Thompson, Henry J ^a   Combs, Gerald F ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SELENIUM;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CANCER PREVENTION; DRUG SAFETY; DRUG TOLERABILITY; MAXIMUM TOLERATED DOSE; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; CLINICAL TRIALS; DISEASE MODELS, ANIMAL; HUMANS; NEOPLASMS; SELENIUM;

EID: 0034930610     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-100103851     Document Type: Review

References (128)

1. Cancer statistics, 2001
2. National health expenditures projections through 2030
3. The costs of cancer care in the United States, implications for action
4. Cancer prevention: The roles of diet and chemoprevention
5. Methodological issues in the design of primary prevention trials
6. The Lessons of Life: Keynote Address to the Nutrition and Cancer Conference
7. Current ideas on selenium as a chemopreventive agent
8. The Role of Selenium in Cancer Prevention
9. Lessons from basic research in selenium and cancer prevention
10. Chemopreventive agents: Selenium
11. Selenium and cancer
12. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: A randomized controlled trial
13. Protective role of selenium against hepatitis B virus and primary liver cancer in qidong
14. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: Complexities with thioredoxin reductase
15. Selenium metabolism and mechanisms of cancer prevention
16. Apoptosis and anti-angiogenesis in cancer prevention by selenium
17. A Genetic model for colorectal tumorigenesis
18. The Hallmarks of cancer
19. Carcinogenesis and cancer: Different perspectives on the same disease
20. Preventive clinical trials: An overview
21. Prevention-therapy-basic science and the resolution of the cancer problem: Presidential address
22. Progress in cancer chemoprevention: Perspectives in agent selection and short-term clinical intervention trials
23. Guidance for development of chemopreventive agents
24. Strategy and planning for chemoprevention drug development: Clinical development plans
25. Strategies for identification and clinical evaluation of promising chemopreventive agents
26. Molecular epidemiology: Insights into cancer susceptibility, risk assessment, and prevention
27. Chemoprevention of prostate cancer: Concepts and strategies
28. Biomarker end-points in cancer chemoprevention trials
29. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer
30. Selenium and cancer: Risk or protection?
31. Selenium
32. Caloric restriction and experimental mammary carcinogenesis
33. The role of calories and caloric restriction in carcinogenesis
34. Effect of dietary supplementation of selenite on pulmonary metastasis of melanoma cells in mice
35. Dietary supplementation of selenomethionine reduces metastasis of melanoma cells in mice
36. Enhancement of BOP-induced pancreatic carcinogenesis in selenium-fed syrian golden hamsters under specific dietary conditions
37. Lack of inhibitory effect of beta-carotene, vitamin C, vitamin E and selenium on development of ductular adenocarcinomas in exocrine pancreas of hamsters
38. The biological availability of selenium in foods and feeds
39. Biological function of selenium-dependent glutathione peroxidase
40. Dietary requirements of selenium for laboratory and livestock species
41. Selenocysteine
42. Functional characterization of the eukaryotic SECIS elements which direct selenocysteine insertion at UGA codons
43. Selenium: Nutritional implications and prospects for therapeutic medicine
44. Selenium-related endemic diseases and the daily selenium requirement of humans
45. Kashin-Beck osteoarthropathy in Rural Tibet in relation to selenium and iodine status
46. Iodine and selenium deficiency associated with creatinism in Northern Zaire
47. Factors influencing blood selenium concentration values: A literature review
48. On the nature of selenium toxicity and carcinostatic activity
49. Selenium and immune responses
50. Supplementation of selenium and human immune cell functions. II. Effect on cytotoxic lymphocytes and natural killer cells
51. Supplementation of selenium augments the functions of natural killer and lymphokine-activated Killer cells
52. Supplementation with selenium and human immune cell Fuctions. I. Effect of lymphocyte proliferation and interleukin 2 Receptor Expression
53. Immune responses in rats supplemented with selenium
54. Selenium and the Immine response: II. Enhancement of murine cytotoxic T-lymphocyte and natural killer cell cytotoxicity
55. Effect of dietary selenium on N-2-fluorenyl acetamide (FFA)-induced cancer in vitamin E-supplemented, selenium-depleted rats
56. Effect of dietary selenium on the metabolism and excretion of 2-acetylaminofluorene in the rat
57. Mechanism of benzylselenocyanate inhibition of azoxmethane-induced colon carcinogenesis in F344 rats
58. Inhibition of 7,12-dimethylbenz(a)anthracene-induced mammary tumors and DNA adducts by dietary selenite
59. Dietary selenite modifies glutathione metabolism and 7,12 Dimethylbenz(a)anthracene conjugation in rats
60. Effect of methylated forms of selenium on cell viability and the induction of DNA strand breakage
61. Selenite induction of DNA strand breaks and apoptosis in mouse leukemia L1210 cells
62. Comparison of the effects of an organic and inorganic form of selenium on a mammary carcinoma cell line
63. Cellular and metabolic effects of triphenylselenonium chloride in a mammary cell culture model
64. The selenium metabolite selenodiglutathione induces p53 and apoptosis: Relevance to the chemopreventive efforts of selenium?
65. Apoptosis induced by selenium in human glioma cell lines
66. Induction of differentiation and apoptosis by sodium selenite in human colonic carcinoma cells (HT29)
67. Involvement of polyamines in selenomethionine induced apoptosis and mitotic alterations in human tumor cells
68. Effects of an aqueous extract of high-selenium garlic on in vitro markers and in vitro efficacy in cancer prevention
69. Dissociation of the genotoxic and growth inhibitory effects of selenium
70. Selenium-induced inhibition of angiogenesis in mammary Cancer at chemopreventive levels of intake
71. Methylselenol as a proximal selenium metabolite that inhibits vascular matrix metalloproteinases and angiogenesis
72. Selenite and selenate inhibit human lymphocyte growth via different mechanisms
73. Selenodiglutathione is a highly efficient oxidant of reduced thioredoxin and a substrate for mammalian thioredoxin reductase
74. 2 toxicity
75. Selenium and thioredoxin and glutaredoxin systems
76. Inhibition of the growth of malignant mouse lymphoid cells by selenodiglutathione and selenocystine
77. Inhibition of protein synthesis and anticarcinogencity of selenium compounds
78. Modulation of oxidative damage to DNA by sodium selenite via the mechanism of apoptosis
79. Factors influencing the anti-tumorigenic properties of selenium in mice
80. Chemopreventive and growth inhibitory effects of selenium
81. Active oxygen generation by the reaction of selenite with reduced glutathione in vitro
82. Comparative effect on inorganic and organic selenocyanate derivatives in mammary cancer prevention
83. Activity of methylated forms of selenium in cancer prevention
84. Comparison of selenium and sulfur analogs in cancer prevention
85. Biological activities of trimethylselenonium as influenced by arsenite
86. Chemical form of selenium, critical metabolites, and cancer prevention
87. Metabolites of sodium selenite and methylated selenium compounds administered at cancer chemoprevention levels in the rat
88. Tamoxifen for prevention of breast cancer: Report of the national surgical adjuvant breast and bowel project P-1 study
89. Can dietary beta-carotene materially reduce human cancer rates?
90. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers
91. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
92. Decreased incidence of prostate cancer with selenium supplementation: Results of a double-blind cancer prevention trial
93. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population
94. Nutrition intervention trials in Linxian, China
95. A Preliminary report on the intervention trials of primary liver cancer in high risk populations with nutritional supplementation of selenium in China
96. Selenium and cancer prevention: Promising results indicate further trials required
97. Selenium-enriched garlic inhibits the early stage but not the late stage of mammary carcinogenesis
98. A case study of nutrient intervention of oral precancerous lesions in India
99. Speciation of selenoamino acids and organoselenium compounds in selenium-enriched yeast using high performance liquid chromatography-inductively coupled plasma mass spectrometry
100. Allium chemistry: Identification of selenoanimo acids in ordinary and selenium enriched garlic, onion and broccoli using gas chromatography with atomic emission detection
101. Studies of safe maximal daily dietary se intake in a seleniferous area in China, 1: Selenium intake and tissue selenium levels of the inhabitants
102. Studies of safe maximal daily dietary se intake in a seleniferous area in China, 2: Relation between se intake and the manifestations of clinical signs and the certain biochemical alterations in blood and urine
103. Effects of selenium excess
104. Essentiality versus toxicity: Some considerations in the risk assessment of essential trace elements
105. Metabolism of subtoxic levels of selenium in animals and humans
106. Studies on human dietary requirements and safe range of dietary intakes of selenium in China and their application in the prevention of related endemic diseases
107. Essentially and toxicity of selenium: A critique of the recommended dietary allowance and the reference dose
108. The consent form as a possible cause of side effects
109. Experimental methods in cancer prevention research
110. Compliance with treatment regimens in chronic asymptomatic diseases
111. Human selenite metabolism: A kinetic model
112. Trends in use of vitamin and mineral supplements in the US: The 1987 and 1992 national health interview surveys
113. Antioxidant effects on selenium and vitamin E function in the chick
114. The role of vitamin E seleniumin the prevention of oxygen-induced tissue damage
115. Protective role of selenium level in toenails and the risk of advanced prostate cancer in Qidong
116. Determination of biomarkers for intermediate end points in chemoprevention trials
117. Selenium modulation of cell proliferation and cell cycle biomarkers in normal and premalignant cells of the rat mammary gland
118. Nuclear texture: Can it be used as a surrogate endpoint biomarker?
119. Morphometric markers for the evaluation of preneoplastic lesions in the lung. Diagnostic evaluation by high-resolution image analysis of atypical cell in sputum specimens
120. Clinical detection of lung cancer progression markers
121. The utility of prostate-specific antigen as a surrogate marker for identification of high-risk cohorts and assessing response in chemoprevention trials
122. Deletion of serum lectic reactive alpha-fetoprotein by acyclic retinoid: A potent biomarker in the chemoprevention of second primary hepatoma
123. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
124. How tumors become angiogenic